We have previously shown that deamidation by TGM2 occurs in β-cells (26), and data from in vitro systems, animal models, and human T1D point to a role for these modified proteins as neoepitopes in T1D (5–8). This evidence concerns the gene TGM2 and type 1 diabetes mellitus.